# OnCo record nct06998173 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06998173/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06998173", "NCT06998173" ;
  schema:name "Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor"@en ;
  schema:description "A phase 1 trial of DAT-1604 run by Danatlas Pharmaceuticals Co., Ltd, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06998173/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06998173> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/dat-1604/> ;
  onco:companies <https://onco.cc/companies/danatlas-pharmaceuticals/> .